Treatment of Adolescent Suicide Attempters (TASA)
The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide...
Brief Summary
The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Detailed Clinical Trial Description
Suicide is the third leading cause of death in adolescents and is a major public health problem. Depression is the most common diagnosis for adolescent suicide attempts. Little is known about what treatment is best for these adolescents since they are usually excluded from participation in research studies.
Participants in this study will be randomly assigned to receive carefully monitored antidepressant medication with routine support and management, cognitive behavioral therapy (CBT), or a combination of antidepressant medication plus CBT.
Intervention(s) in this Clinical Trial
- Drug: fluoxetine
- Drug: sertraline
- Drug: citalopram
- Drug: escitalopram
- Drug: bupropion
- Drug: mirtazapine
- Drug: venlafaxine
- Drug: lithium
- Behavioral: Cognitive Behavioral Therapy
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- At least one suicide attempt or interrupted attempt within the past 45 days
- Continuously reside with a primary caretaker (parent, legal guardian, foster parent) for at least 6 months that can provide legal consent
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 12 Years
Maximum Age for this Clinical Trial: 18 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: National Institute of Mental Health (NIMH) NIH
Overall Clinical Trial Officials and Contacts
Laurence Greenhill, MD Study Chair
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00080158
Study ID Number: U10 MH66762
ClinicalTrials.gov Identifier: NCT00080158
Health Authority: United States: Food and Drug Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00080158
